Reporting owner · CIK 0001855616

Morrell Martha

Visual SEC Form 4 history across 1 companies, 42 transactions and 7 filings.

CMOCHIEF MEDICAL OFFICERNeuroPace Inc
Open-market mix
Latest filingAug 28, 2026, 09:03 PM
Filings7Form 4 records
Buying$00 purchases
Selling$1.1M4 sales
Net value−$1.1MBuys minus sells
Companies13 securities
Most recentAug 27, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Apr 24May 24Jun 24Jul 24Aug 24Sep 24Oct 24Nov 24Dec 243Jan 251Feb 25Aug 26

Net value flow

Buys minus sells

Jun 24
$0
Jul 24
$0
Aug 24
$0
Sep 24
$0
Oct 24
$0
Nov 24
$0
Dec 24
$0
Jan 25
−$52.5K
Feb 25
−$1.1M
Aug 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$281.8K
Median P/S size$25.5K
Direct42
Indirect0
Aug 27, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern1Delayed Filingfiling-context35Derivative Transactionfiling-context5Direct Ownershipfiling-context42Large Holdings Increaseholdings2Large Holdings Reductionholdings4Large Salesize1Repeat Sellerpattern110b5-1 Detectedfiling-context4

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at NeuroPace Inc on Feb 21, 2025 valued at $1,074,844.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Associated companies

Visual map of known reporting history

NPCENeuroPace Inc42 transactions · latest Aug 28, 2026, 09:03 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
NPCEMorrell Martha
CMO
exercise12.2k$31.8kM
Delayed Filing Direct Ownership
—02/25/202501/31/2024
NPCEMorrell Martha
CMO
exercise192$499M
Delayed Filing Direct Ownership
—02/25/202501/31/2024
NPCEMorrell Martha
CMO
exercise192$499M
Delayed Filing Direct Ownership
—02/25/202501/31/2024
NPCEMorrell Martha
CMO
exercise192$499M
Delayed Filing Direct Ownership
—02/25/202501/31/2024
NPCEMorrell Martha
CMO
withholding3.40k-$4.84MF
Direct Ownership
—02/25/202502/20/2025
NPCEMorrell Martha
CMO
withholding265-$372kF
Delayed Filing Direct Ownership
—02/25/202501/22/2025
NPCEMorrell Martha
CMO
withholding1.41k-$1.68MF
Delayed Filing Direct Ownership
—02/25/202512/03/2024
NPCEMorrell Martha
CMO
withholding3.04k-$2.79MF
Delayed Filing Direct Ownership
—02/25/202511/20/2024
NPCEMorrell Martha
CMO
withholding237-$142kF
Delayed Filing Direct Ownership
—02/25/202510/22/2024
NPCEMorrell Martha
CMO
withholding1.33k-$985kF
Delayed Filing Direct Ownership
—02/25/202509/03/2024

Morrell Martha Insider Activity FAQ

SEC Form 4 context

Who is Morrell Martha?

Morrell Martha is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001855616.

Which companies has Morrell Martha reported transactions for?

NeuroPace Inc

When was Morrell Martha's latest insider buy?

No open-market insider purchase is available for this period.

When was Morrell Martha's latest insider sale?

sale at NeuroPace Inc on Feb 21, 2025 valued at $1,074,844.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.